Germany · Biopharma startup
Germany · Isotopen Technologien München
Isotopen Technologien München is a holding company that owns biotechnology and radiopharmaceutical companies.
Funding reportedLast round: Private equity
Follow Isotopen Technologien München and see its new rounds in your feed.Start following
What company datasets say Isotopen Technologien München raised
Funding, as reported
Reported in all676Min the source's currency
Rounds8
Last roundPrivate equity
Last round dateJun 2024
Investors listed13
Founders and team
From Isotopen Technologien München's own website: 8 on the team.
- Alexander PironiExecutive Vice President, Global Head of Radioisotopes
- Roger EstafanosExecutive Vice President, Global Head of Radiopharmaceuticals
- Annette BreunigChief People Officer ITM Group
- Dr. Celine WilkeChief Medical Officer of ITM
- Jutta LehmannHead of Global Quality of ITM Group
- Kathleen NoonanHead of Corporate Communications
- Marc ScharrerGeneral Counsel, Head of Legal
- Merle WagnerCorporate Secretary & Compliance Officer
On 5 portfolio pages
Investors who name them
Each firm lists Isotopen Technologien München on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.
Biopharma in Germany
Startups like it
Is this your company?
Add your raise, your deck and your story, and put Isotopen Technologien München in front of investors. Or tell us what we have wrong.